Group One Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-27,906
| Closed | -$1.34M | – | 8163 |
|
|
2025
Q3 | $1.26M | Sell |
27,906
-23,845
| -46% | -$1.11M | ﹤0.01% | 2786 |
|
|
2025
Q2 | $2.4M | Buy |
51,751
+45,978
| +796% | +$2.26M | 0.01% | 1957 |
|
|
2025
Q1 | $352K | Buy |
+5,773
| New | +$337K | ﹤0.01% | 3439 |
|
|
2024
Q3 | – | Sell |
-130,790
| Closed | -$6.14M | – | 6667 |
|
|
2024
Q2 | $5.43M | Buy |
130,790
+41,476
| +46% | +$1.86M | 0.02% | 756 |
|
|
2024
Q1 | $4.84M | Buy |
89,314
+63,638
| +248% | +$3.24M | 0.02% | 847 |
|
|
2023
Q4 | $1.32M | Sell |
25,676
-22,723
| -47% | -$1.19M | ﹤0.01% | 2207 |
|
|
2023
Q3 | $2.81M | Buy |
+48,399
| New | +$2.97M | 0.01% | 1365 |
|
|
2023
Q1 | – | Sell |
-127,033
| Closed | -$8.96M | – | 7224 |
|
|
2022
Q4 | $9.14M | Buy |
127,033
+80,602
| +174% | +$6.08M | 0.02% | 790 |
|
|
2022
Q3 | $3.3M | Buy |
+46,431
| New | +$3.37M | 0.01% | 1500 |
|
|
2022
Q1 | – | Sell |
-228,990
| Closed | -$15.4M | – | 8037 |
|
|
2021
Q4 | $14.3M | Sell |
228,990
-12,662
| -5% | -$743K | 0.01% | 855 |
|
|
2021
Q3 | $14.3M | Sell |
241,652
-37,751
| -14% | -$2.49M | 0.02% | 815 |
|
|
2021
Q2 | $18.7M | Buy |
279,403
+42,237
| +18% | +$2.75M | 0.02% | 674 |
|
|
2021
Q1 | $15M | Sell |
237,166
-54,342
| -19% | -$3.38M | 0.02% | 686 |
|
|
2020
Q4 | $18.1M | Buy |
291,508
+179,460
| +160% | +$11M | 0.03% | 494 |
|
|
2020
Q3 | $6.75M | Buy |
112,048
+5,368
| +5% | +$323K | 0.02% | 726 |
|
|
2020
Q2 | $6.27M | Buy |
106,680
+15,476
| +17% | +$926K | 0.03% | 673 |
|
|
2020
Q1 | $5.08M | Buy |
+91,204
| New | +$5.57M | 0.04% | 526 |
|
|
2019
Q4 | – | Sell |
-16,089
| Closed | -$921K | – | 5129 |
|
|
2019
Q3 | $816K | Buy |
+16,089
| New | +$756K | 0.01% | 1912 |
|
|
2019
Q2 | – | Sell |
-105,621
| Closed | -$4.92M | – | 4958 |
|
|
2019
Q1 | $5.04M | Sell |
105,621
-135,975
| -56% | -$6.77M | 0.06% | 416 |
|
|
2018
Q4 | $12.6M | Buy |
241,596
+223,405
| +1,228% | +$12M | 0.11% | 176 |
|
|
2018
Q3 | $1.13M | Sell |
18,191
-144,842
| -89% | -$8.6M | 0.01% | 1611 |
|
|
2018
Q2 | $9.02M | Buy |
163,033
+108,503
| +199% | +$5.86M | 0.08% | 282 |
|
|
2018
Q1 | $3.45M | Sell |
54,530
-128,416
| -70% | -$8.26M | 0.03% | 662 |
|
|
2017
Q4 | $11.2M | Sell |
182,946
-48,448
| -21% | -$3.03M | 0.08% | 304 |
|
|
2017
Q3 | $14.7M | Sell |
231,394
-102,718
| -31% | -$6M | 0.13% | 162 |
|
|
2017
Q2 | $18.6M | Sell |
334,112
-36,983
| -10% | -$2.01M | 0.19% | 92 |
|
|
2017
Q1 | $20.2M | Buy |
371,095
+147,440
| +66% | +$8.09M | 0.24% | 72 |
|
|
2016
Q4 | $13.1M | Buy |
223,655
+151,624
| +210% | +$8.29M | 0.13% | 163 |
|
|
2016
Q3 | $3.88M | Buy |
+72,031
| New | +$4.63M | 0.04% | 519 |
|
|
2016
Q2 | – | Sell |
-14,380
| Closed | -$1.02M | – | 4615 |
|
|
2016
Q1 | $919K | Buy |
+14,380
| New | +$907K | 0.01% | 1236 |
|
|
2015
Q4 | – | Sell |
-130,567
| Closed | -$8.63M | – | 4741 |
|
|
2015
Q3 | $7.73M | Buy |
130,567
+92,336
| +242% | +$5.86M | 0.11% | 211 |
|
|
2015
Q2 | $2.54M | Buy |
38,231
+22,553
| +144% | +$1.49M | 0.04% | 609 |
|
|
2015
Q1 | $1.01M | Buy |
15,678
+7,978
| +104% | +$499K | 0.02% | 1072 |
|
|
2014
Q4 | $455K | Buy |
+7,700
| New | +$434K | 0.01% | 1618 |
|
|
2013
Q4 | – | Sell |
-100
| Closed | -$5K | – | 5213 |
|
|
2013
Q3 | $5K | Buy |
+100
| New | +$4.39K | ﹤0.01% | 4740 |
|
Other funds holding BMY
VCM
VPM
Group One Trading's BMY Position: Q4 2025 in Review
Group One Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 27,906 shares — an estimated $1.34M sold.
Group One Trading first reported a position in BMY in Q3 2013 and held it in 35 quarters. The position peaked at $20.2M in Q1 2017. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Group One Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 27,906 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.34M.
- Group One Trading first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 35 quarters.
- Group One Trading's Bristol-Myers Squibb position peaked at $20.2M in Q1 2017.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.